PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Angela Alibrandi

Unit of Statistical and Mathematical Sciences, Department of Economics, University of Messina, Messina, Italy.

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

JUL 30, 2026 · JOURNAL ARTICLE

Feasibility and safety of recombinant zoster vaccination in patients undergoing active cancer treatments: A real-world single-center experience.

Human Vaccines & Immunotherapeutics

Single-center retrospective observational study of modest size with no control group, reporting feasibility and safety outcomes but lacking power to assess efficacy and generalizability.

PreliminaryCancer Patients Giordana Di Mauro Herpes Zoster Vaccine

Reported

Patients completing two-dose sche…37 of 42 (88.1%)

Median follow-up duration11.5 months

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support